International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 140,673 IPC common shares (ISIN: CA46016U1084) during the period of September 1 to 4, 2026 under IPC’s previously announced normal course issuer bid / share repurchase program (NCIB).
Originally published via Source Article.
TORONTO, Ontario, Sept. 04, 2026 (GLOBE NEWSWIRE) — Avante Corp. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”), a global provider of technology-enabled security solutions and services, today (the “Grant Date”) announces that it has approved the issuance of 100,000 stock options (each, an “Option”) to a certain senior employee of a subsidiary of the Company for the purchase of up to 100,000 common shares in the capital of the Company (each, a “Share”) pursuant to the Company’s 10% rolling stock option plan (the “Plan”). The grant of Options is subject in all respects to the terms of the Plan.
CALGARY, Alberta, Sept. 04, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) today reported significant progress in the continued execution of its Phase III shareholder value creation plan, announced on August 17, 2026, as part of the Company’s strategy refresh in connection with the management team transition initiated in Q2 2026. The Company’s rental fleet is ready for deployment, commercial activity is advancing across North America, Africa and the Middle East, and a strategic partnership in Mexico is opening the path to a Pemex enterprise-wide contract.
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has entered into media and digital marketing agreements to support increased market awareness of the Company.
CALGARY, Alberta, Sept. 04, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) today reported significant progress in the continued execution of its Phase III shareholder value creation plan, announced on August 17, 2026, as part of the Company’s strategy refresh in connection with the management team transition initiated in Q2 2026. The Company’s rental fleet is ready for deployment, commercial activity is advancing across North America, Africa and the Middle East, and a strategic partnership in Mexico is opening the path to a Pemex enterprise-wide contract.
Originally published via Source Article.
CALGARY, Alberta, Sept. 04, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) today reported significant progress in the continued execution of its Phase III shareholder value creation plan, announced on August 17, 2026, as part of the Company’s strategy refresh in connection with the management team transition initiated in Q2 2026. The Company’s rental fleet is ready for deployment, commercial activity is advancing across North America, Africa and the Middle East, and a strategic partnership in Mexico is opening the path to a Pemex enterprise-wide contract.
Originally published via Source Article.
CALGARY, Alberta, Sept. 04, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) today reported significant progress in the continued execution of its Phase III shareholder value creation plan, announced on August 17, 2026, as part of the Company’s strategy refresh in connection with the management team transition initiated in Q2 2026. The Company’s rental fleet is ready for deployment, commercial activity is advancing across North America, Africa and the Middle East, and a strategic partnership in Mexico is opening the path to a Pemex enterprise-wide contract.
Originally published via Source Article.
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has entered into media and digital marketing agreements to support increased market awareness of the Company.
Originally published via Source Article.
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has entered into media and digital marketing agreements to support increased market awareness of the Company.
Originally published via Source Article.
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has entered into media and digital marketing agreements to support increased market awareness of the Company.
Originally published via Source Article.
